1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Texas >
  6. AngioSoma Acquires Diabetes Relief

M&A Deal Summary

AngioSoma Acquires Diabetes Relief

On December 14, 2018, AngioSoma acquired healthcare services company Diabetes Relief

Acquisition Highlights
  • This is AngioSoma’s 1st transaction in the Healthcare Services sector.
  • This is AngioSoma’s 1st transaction in the United States.
  • This is AngioSoma’s 1st transaction in Texas.

M&A Deal Summary
Date 2018-12-14
Target Diabetes Relief
Sector Healthcare Services
Buyer(s) AngioSoma
Deal Type Add-on Acquisition

Target

Diabetes Relief

Houston, Texas, United States
Diabetes Relief LLC is a provider of medical facilities for the treatment of metabolic disorder, specializing in diabetes, for the use of patented protocols, processes, and intellectual property. Diabetes Relief is based in Houston, Texas.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

AngioSoma

Houston, Texas, United States
Category Company
Sector Medical Products
DESCRIPTION

AngioSoma, Inc. is a provider of supplements for improving the mental and physical well-being of men and women, underSomaceuticals™ common identity. AngioSoma is based in Houston, Texas.

DEAL STATS #
Overall 1 of 1
Sector: Healthcare Services M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Texas M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2018 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal